Thank safe. and you, morning, unprecedented thanks your all And challenging hope us. I and for finds this joining Susan. Good times, of these and Particularly well during you everyone. families
to what environment. current we're data in and taking this review points relevant different call that a on today the be morning, seeing also the COVID-XX mostly a first but are other of approach our the field quarter, focusing We'll in
on We program before questions. will your also briefly turning to development our strategies our business and EXPAREL, efforts iovera° our for touch
Pacira the at the virus. our community has employees in the providing aid pain alternative an priority of to those patients and highest Our safe to order patients, global opioid-free containment while in keeping been COVID-XX
elective have leader eased These limited to surgery calls which ASCs, centers, ambulatory focus training taking reimbursement and surgery end, have teams remained began working office been that using mid-March, tools, teams hospital Toward recently most been and of key customer, bans digital clinical education highly virtual and lifted. and lab-based primarily our product have colleagues where preceptorships. on support or programs our and opinion from providing sales home. Since productive, or
of shares had commitment Medical to pain opioid-sparing During the new and Don patients. Manning. bringing welcoming this Chief work-from-home management our brings extensive experience period, a we Don to Officer, pleasure
our him have to thrilled and contributions. his join looking forward executive to team are leadership We we're
what both in more our do The the will long this data we the asked that impact term. pandemic have know business you the is simple how of until answer fully field. short be Many we affecting from is and points not have
we online several do and other elective shortly. EXPAREL week-over-week the We the data the coming showing on with states very surgery more two for are to point which that see with this restrictions, side growth, I'll weeks encouraging. now starting believe is touch of last
We to continue alternative do require opioid-free and patients that know will control. surgeries pain all deserve their elective emergent and an that for
temporary. disruption surgeries a We be on also will believe these as that of COVID-XX result
also COVID-XX seasonal speculate a the of While of procedures. of we cannot factors number terms impact, when duration schedule on may change patients in elective
we the dips example, may not late in August. surgeries seasonal usual For have in
while in Ambulatory surgical in also patients of more from for hospital, surgery crowded the hospitals. offer system in patients COVID-XX healthcare an allowing for the outpatient the isolation for patients capacity providing centers ASC and staging the by solution away environment,
Importantly, the post-surgical use procedures, market's the of and number opioid-sparing long-term EXPAREL trends, with for desire an increasing the pain expanding of highlights management. along
the of demand the the rates weeks of and growth by tracking plan for growing for year-over-year unabated EXPAREL, XX% continued first with and year, supported for is which XX February. for January sales XX% This ahead of
hold community to variety continue as nerve anesthesia and demand saw the blocks field protocol with procedures. surgical EXPAREL-based within of blocks We expand a taking for institutional
while guidance million, the growth long-term our quarter in line XX% times, first high strong very is a with top revenues line this even challenging in had year-over-year these teens. total growth We of $XXX.X for in with
annual guidance. our pausing are we Today,
to be specifically, backlog the surgeries a relieved. be surgical when on hospitals in to projections look quickly provide unprecedented position We resume more have we greater our insight once into this will XXXX data and real-world can will elective granularity and how situation,
expenditures, operating revenues, very well in disruption curtailing are for ramp full to of restrictions, will we from world be and resulting adjusted business. as reopens positioned Even with short-term quickly the positive allow significant year, EBITDA a believe for COVID-XX to we us still natural up the the
footing on in Importantly, cash $XXX solid with investments. and financial million we are
to some recent questions gotten in on we also are touch iovera° this manufacturing the manufacturing our in as EXPAREL fully The operate. like operational weeks. are I'd essential we've in deemed as of they and which on states
disruption necessary of aspects or We needed inventory have ensure for in any not had patients. to manufacturing supply any sourcing our API
temporary a by protocols. so iovera° production order, three-week is and a triggered in other social the running up distancing California, that and team place back shelter halt implement Fremont, proper safety after in could
exposure any have have and late or of not any from of do any or China learned our not Italy in We deliveries supply interruptions suppliers.
today, our We we of no closely. have chain monitoring supply as And issues. are
sufficient With expectations our to we revenue supply in have ongoing, original manufacturing operations any satisfy surge demand. and inventory XXXX
the Let's came fact essentially activity of turn quarter halt that we in personal XX% first now and detailed mid-March. of where discussion despite XXXX, sales economic to to year-over-year product a a EXPAREL, the during growth in more a posted nearly
We half period. in with saw XX% decline of year-over-year during precipitous begin a in second a March the sales continue EXPAREL and the end April this through drop approximately of of
ago these now over we possible, we Friday this ending with numbers comparing a to weeks as ago states surgical of lifting have this two restrictions, seen week rebound the one week past However, weeks. to To are morning. real-time and three signs positive Thursday make as
EXPAREL last XX% a see of week, increase an morning. this last Comparing customers Again, weeks this sales. real-time to week comparing to XX% this ordering EXPAREL XX% ago, additional as And increase a increase customers ordering increase in we XX% week a two in and is sales. saw in in and we
we will very the states will quickly encouraging, long hospital stay-at-home sales usual. or orders these inpatient how While not some mandate data community, especially do return know as are and business recent surgical to how surgery,
is time surgery teams planning anticipation demand the volumes on when the limited, our targeting building. During surgical in of focused elective address and education, are is increased to that
reduce stay This it is today hospital currently education out how important infection enabler painful reduced only are we to the hospital through of of length an analgesia. knee XX-hour is providing is is as to healthcare a such EXPAREL beds, example healthcare to patients solution. get regional is of not providers EXPAREL but work An of trend the in release risk many arthroplasty, environment key total where procedures, and and perfect shifting the the surgery as the large spine with also of
before settings that ASCs from In the believe fact, pandemic. taking to we this migration situation accelerate was the actually COVID-XX may that place already inpatient
motivated and more resources are hospital avoid than deployed patients. to be to hospital Patients sickest continue to the ever stays,
is a surgeries the not reduce is this as see those ICU necessitated XX-hour recovery aim to to preferable in we the for stay where surgical Additionally, we virus exposure transition for and which setting.
states see customer increase allowing are including the can from growing you in now and hospital ASCs in a relaxing elective of EXPAREL, outpatient and mandates As surgeries, number rapid facilities. of ordering
Florida, anesthesia as the the Texas, an in and to allowing such begin elective of patients. California, states surgical and We are Georgia, with states, working key York, well backlog as treating procedures communities closely as New Ohio surgical additional XX currently
with surgical time ASCs hospitals, COVID-XX back them. they expect when we to ramp in As lockstep recover admit need to up to ready than start burden, come we to are patients, more online which the from earlier will
hospital As setting of a being performed QX reminder, the of were outside in of XX% inpatient procedures already XXXX. EXPAREL-relevant
These planning been quickly Our possible as operate ASC are deprived cases, patients and, speed to surgical back in six have interventions. important to are eager who days benefit seven of facilities or customers get to as a to their many week up XX/X.
and payment To out offices with surgical a maxillofacial oral extended activity, a June, order centers, ambulatory to plastic which terms. surgery facilitate we offers EXPAREL at and have this rolled through program available practices discount
expectations more Our than XX% in are up rescheduled, will made lion's of the be the delayed share with XXXX. that procedures
dramatic with opinion joint DePuy partners reconstruction, medicine leaders in closely with when We in reduction surgeries. orthopedic scheduled and at and surgeons been a have spine key of the Synthes also experienced working have time sports our at area a
in especially access XX-hour hospital creating to EXPAREL marketing care. to not have EXPAREL-based we procedures, and shift orthopedic reduced and setting. enabler spine, ASC is of to stay as to like regional surgeons had virtual approaches TKA materials the in to This on length major for when new the side important important provide education operating of surgeons of their around Here, an new focused have
EXPAREL-based some opioid While of fully EXPAREL time terms lower elective be before to the use, procedures largely the to that no be we surgical second us half in we of of return backlog we open the and it year is in support patients or to ahead normal believe expect through opportunity likely strategies. market is addressing all to significant to
oncology, drivers, our That also have the and C-section well said, marketplace continue as by elective surgery. as driven to that and be the breast emergent markets cases, use such is demand cardiovascular in being we of procedures and and restricted as gynecologic continues base to EXPAREL expect of a of current cancer, spine trauma EXPAREL even access surgery, growth non-elective business to given increase one C-section in with Increasing use top dynamics. to we
continue women hospital. hesitant want the C-sections already and are admitted experience. Most birth to being very limiting scheduled and women presence occur, hospitals of partners restricting many the While an to are about pregnant opioid-free
benefits accelerating TAP of is the to block. this our training EXPAREL So, programs an opioid-sparing anesthesia
marketing broad and for the launched only program We XXXX. in awareness early C-section
infancy the this opportunity we patient care tapping near-term and a segment this in to improve we're of economics. So, hospital as terrific market see and
and opioid-free hospital benefits block in More the CHOICE highlighting for growing our XXX TAP than the spend payers C-section. which mothers for webinar a policy new decision-makers hosted the time participated, recently limiting We of the underscores EXPAREL-based a demand providers, study. from
robust procedural EXPAREL block, of but as are arthroplasty and studies timely growth. solution. study IV each to look for you our now, IV forward study procedures we STRIDE a manner. we to As our PREPARE FUSION include have as a EXPAREL Phase in in total extremity EXPAREL completing drive and clinical knee III a These Phase intended iovera° in on pause a of our study know, Phase lower program spine These nerve
Canada is EU and progressed The the date, communications. by EXPAREL securing interactions and Canada of toward in agencies Europe approvals using regulatory To end XXXX. also team virtual the with have working in
critical perspective, payers. all strategic options population. manage There is key doctors to an label pain a in children, and – is on for stakeholders our From non-opioid having of urgent to pediatrics parents, this need importance vulnerable post-surgical
track next the pediatrics weeks. in to submit we to on sNDA Here, our few remain
and line, once international in Building growth confident COVID-XX, managed position margins on we growing new XXXX top in our we other deliver launches, to expenses. remain insert multiple disruptions a and procedural that rapidly due package expansions operating as side improving will the data XX% to steadily of as sets, well be EXPAREL appropriately
have business The while that opportunity to simultaneously invest tremendous lines. is bottom the top ramping we a takeaway and in here our
iovera°. Now turning to
and be system this represents. significant to highly commercial innovative confident the opportunity continue We technology it that behind the
given delayed We impact national the are And meeting now iovera° we our February. iovera° kicked at off launch a The relaunch suspending result, a temporarily sales of of in guidance. COVID-XX. is as
recently We incremental will containing a provider procedures management treatment flow pain introduced reduced This while an of course, due orthopedic customers delayed practices initiative, a all generating help of concurrently our during patients components this This offering offer kit TKA will, COVID-XX. patients iovera° have difficult to to who at help for price. cryoanalgesia cash time.
the last needs, to surgeons weeks, their as orthopedic as how but series we've with well patients several customer-facing of provides pain a daily has are Over osteoarthritic have preparing whose delayed impacting patients life. our patients held webinars of of across a for iovera° well surgery, hoping to who been patient TKA surgery surgery pain six range delay control as discuss months as organization
We are programs our iovera°. also for with continuing development
and study, for range spasticity, ribs, low In clinical we fractured the data study pain, addition of are in a back spine ankle EXPAREL and iovera° TKA, launching pain, developing wide treatment plus shoulder of examples. as a to and opportunities foot PREPARE
over turning on like to to the Before business call Charlie, comment briefly I'd development. the
also thoughtfully complementary the anesthesia pursue on to to we audiences are existing call continue our and offerings today. We surgical opportunistically and to interest that assets of
will That anesthesiologists, partners, are said, avoid requirements our in heavy and near-term. we on any cash surgeons laser-focused supporting the and upfront
you ourselves in of the me unique find we remind today. opportunity Let
the patients – allows the COVID-XX Our the innovative two crisis pandemic, by non-opioid the surgery in pain delay that been as has public health national well of opioids to products with awaiting and address portfolio ongoing surgery. demand opioid driven control of the for requiring backlog crises while further us as exacerbated
to a like Charlie call of And financials. the review over to Charlie? I'd with that, the for turn
